Promising data from early stage human trials of HIV vaccine

Vaccinating against HIV is the “Holy Grail” of scientific research. However, due to the complex nature of the virus, which is among the most genetically diverse known viruses, many have considered it impossible to vaccinate against. The latest research however, reveals that a new vaccine for HIV AIDS may be closer than we think. Developed…

Read More

A potential vaccine for cancer: new data

After nearly half a century of trying to identify a vaccine that might wipe out cancers, similarly to the way vaccine targets influenza or pneumococcal pneumonia, scientists might have made a breakthrough in this arena. According to an article published in The Australian (July 7, 2017), scientists from a German biotechnology company, Biontech, as well as…

Read More

Apotex launches Oviit a new range of vitamins and minerals

Apotex announced the launch of its new premium value, Pharmacy Only range of vitamin and mineral supplements (VMS), Oviit today (July 3, 2017). Expansion into this high growth VMS category signals further diversification of Apotex’s over-the-counter (OTC) portfolio, and a strategy for the generic drug manufacturer to restore value to the VMS category for pharmacy.…

Read More

Aussie biotech appoints American royalty to its Board of Directors

VIVA! Communications are thrilled to be working with Australian medical technology company Medibio as they today (June 4, 2017) announce the appointment of mental health advocate and former U.S. congressman, Patrick J.  Kennedy, to their Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives and America’s leading political…

Read More